Search results
6 sie 2024 · Women diagnosed with gynecologic cancer who underwent their first in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment between 2013 and 2021 at Shanghai Ji Ai Genetics and IVF Institute were included in this study.
5 wrz 2024 · In this multicenter, non-inferiority, randomized trial, we randomly assigned 992 women undergoing in-vitro fertilization (IVF) with a good prognosis (aged 20-40, ≥3 transferrable...
16 lip 2020 · The long-term use of IVF medications can increase estrogen hormones and cause excessive expression of genes, resulting in an increased risk of breast cancer, which is one of the most frequent cancers among women.
22 sie 2019 · Results. Women of a median age of 34 years (range 26–41 years) underwent a total of 49 embryo transfers within an average of 2 months after their last progestin treatment. The clinical pregnancy rate per transfer was 26.5%, implantation rate was 16.7%, and live birth rate was 14.3%.
IVF with cryopreservation of embryos allows embryo banking before chemotherapy for women who have been newly diagnosed with cancer. Factors related to the partner affect the success of IVF for male factor infertility as a result of cancer treatment.
22 wrz 2020 · Oocytes and embryos can be safely and efficiently cryopreserved before the initiation of anticancer treatments. While embryo cryopreservation is an established and reproducible technology, it requires the use of sperm and the presence of a partner or donor.
9 lut 2022 · This meta-analysis of 25 studies published within the last 20 years did not find a significant association between fertility treatments and excess breast-cancer risk. Women considering IVF should be informed that IVF does not appear to increase breast-cancer risk.
